Clinical Trials Directory

Trials / Completed

CompletedNCT01339013

Rebreathing of Carbon Dioxide With a Device Used for Giving Inhalational Anaesthesia

Dead Space Effect of an Anaesthesia Gas Reflector (AnaConDa)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Region Skane · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The anesthesia gas reflector (AnaConDa) is built on the adsorptive capacity of active carbon which also adsorbs carbon dioxide in exhaled air. Rebreathing of carbon dioxide thus occurs and must be compensated for by increased ventilation. This study aims at determining how much compensation must be given, based on the hypothesis that rebreathing depends on carbon dioxide level in blood and exhaled air.

Conditions

Interventions

TypeNameDescription
DEVICEAnesthetic Conserving Device (AnaConDa )Standard HME was replaced by AnaConDa. AnaConDa has charcoal filter, HME does not.

Timeline

Start date
2011-04-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2011-04-20
Last updated
2014-09-25
Results posted
2014-09-11

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01339013. Inclusion in this directory is not an endorsement.